tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
KYTX
Kyverna Therapeutics, Inc.
RESEARCH TOOLSreports
Advertisement

Kyverna Therapeutics, Inc. (KYTX) Stock News & Sentiment

Compare
801 Followers
Kyverna Therapeutics Secures $150 Million Loan Facility
Premium
Company Announcements
Kyverna Therapeutics Secures $150 Million Loan Facility
7d ago
8K
KYTX
3 Best Stocks to Buy Now, 10/30/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 10/30/2025, According to Top Analysts
11d ago
KYTX
OPRA
Promising Phase 2 Data and Favorable Safety Profile Drive Buy Rating for Kyverna Therapeutics’ KYV-101
Premium
Ratings
Promising Phase 2 Data and Favorable Safety Profile Drive Buy Rating for Kyverna Therapeutics’ KYV-101
11d ago
KYTX
Kyverna Therapeutics’ KYV-101 Shows Promising Phase II Results in gMG, Supporting Buy Rating
Premium
Ratings
Kyverna Therapeutics’ KYV-101 Shows Promising Phase II Results in gMG, Supporting Buy Rating
11d ago
KYTX
Kyverna Therapeutics Reports Positive Phase 2/3 Trial Data
Premium
Company Announcements
Kyverna Therapeutics Reports Positive Phase 2/3 Trial Data
12d ago
8K
KYTX
Kyverna Therapeutics Reports Positive Phase 2 Trial Results
Premium
Company Announcements
Kyverna Therapeutics Reports Positive Phase 2 Trial Results
12d ago
8K
KYTX
Kyverna Therapeutics Advances CAR T-Cell Therapy Study for Myasthenia Gravis
Premium
Company Announcements
Kyverna Therapeutics Advances CAR T-Cell Therapy Study for Myasthenia Gravis
13d ago
KYTX
More KYTX News >

KYTX News on the Web

Why Kyverna Therapeutics, Inc.’s (KYTX) Stock Is Down 6.91%
AAII
Neutral
Why Kyverna Therapeutics, Inc.’s (KYTX) Stock Is Up 5.66%
AAII
Neutral
3 Best Stocks to Buy Now, 10/30/2025, According to Top Analysts
TipRanks News
Neutral
Kyverna Therapeutics Reports Positive Phase 2 Trial Results
TipRanks News
Neutral
Kyverna’s KYV-101 Shows 100% Response Rate and No Severe Side Effects in Interim Phase 2 Myasthenia Gravis Study
Market Chameleon
Neutral
Why Kyverna Therapeutics, Inc.’s (KYTX) Stock Is Down 5.12%
AAII
Neutral
KYV-101 Shows Encouraging Results in Hard-to-Treat Rheumatoid Arthritis—Phase 1 Data Signals Safety and Potential Efficacy
Market Chameleon
Neutral
KYV-101 Shows Promise in Difficult-to-Treat Rheumatoid Arthritis: Profound Autoantibody Reductions and Well-Tolerated Profile Highlighted in Phase 1 Data
Market Chameleon
Neutral

News Score - Last 7 Days

Neutral
KYTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.75 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KYTX’s Media Buzz Sentiment?
2 articles about KYTX were published this week. In an average week, 3.75 articles are published.
    What is KYTX’s weekly average amount of articles?
    In an average week, 3.75 articles about KYTX are published.
      What is KYTX’s News Sentiment?
      50% of articles about KYTX were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        LSTALisata Therapeutics
        ACADACADIA Pharmaceuticals
        ALKSAlkermes
        IDXXIdexx Laboratories
        STESteris
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing